<DOC>
	<DOCNO>NCT02816827</DOCNO>
	<brief_summary>The current study design asses effect E-AG-01/ E-AG-02/ E-AG-03 mental alertness compare placebo .</brief_summary>
	<brief_title>A Study Evaluate Efficacy IP Alertness Mental Fatigue</brief_title>
	<detailed_description>Intake caffeinated drink know improve energy level , alertness , concentration level . Caffeine stimulant central nervous system therefore probably commonly use psychoactive substance world . Caffeine intake prefer many individual moderate amount caffeine consumption postulate certain beneficial effect nervous system well general well-being , like increase level alertness diminution exhaustion especially low arousal circumstance ( e.g . work night ) , improvement performance vigilance task simple task require sustain response . Along virtue caffeine intake associate certain demerit also . High dose caffeine 400 mg day healthy adult may associate adverse event psycho motor agitation , insomnia , headache , gastrointestinal complaint depend several lifestyle parameter . Since caffeine intake habitual , withdrawal caffeine pose certain concern performance like negative impact mood level follow withdrawal . Hence always need find alternative caffeine attribute caffeine associate habit form stance . In order fulfill unmet need Enovate Biolife design novel natural caffeine free ingredient postulate enhance mental alertness combat mental fatigue similar caffeine without cause adverse effect associate caffeine .</detailed_description>
	<mesh_term>Fatigue</mesh_term>
	<mesh_term>Mental Fatigue</mesh_term>
	<criteria>Healthy Male female computer literate subject ( able use computers/related technology efficiently ) age group 1840 year age . Subject moderate caffeine consumer . All subject predominantly right hand . Subject body mass index ( BMI ) ≥18.5 &lt; 25.00 kg/m2 . Subjects Generalized Anxiety Disorder Screener ( GAD7 ) score ≤ 7 . Subjects screen depression Patient Health Questionnaire9 ( PHQ9 ) score ≤ 14 . Subjects score least 50 ± 20 two three reading Jin Fan 's Attention Network Test ( ANT ) version 1.3.0 24 hr caffeine abstinence perform interval 3060 min . Subject willing refrain consume caffeine caffeinecontaining product 24 hr prior enrollment study prior visit site . Subject agree refrain use turmeric , ginger , cardamom , lemon grass , galangal , beetle leave , beetle nut contain product like thai food , tea masala , thai sauce , mouth freshener , paan , etc day prior clinic visit . Subject willing refrain vigorous physical activity 12 hr prior clinic visit . Subject complete least 78 hour sleep night prior clinic visit . Subject nonsmoker . Female subject currently menstrual period include last day menstrual flow . Female Subjects consume oral contraceptive include study washout period 7 day willing stop use study opt barrier contraceptive method . Subject understands study procedure sign informed consent form participate study authorization release relevant protect health information study Investigator . Subjects unable abstain caffeine contain product 24 hr . Subjects suffer primary secondary insomnia with/ without active treatment . Subjects Generalized Anxiety Disorder Screener ( GAD7 ) score &gt; 7 . Subjects Personal health Questionnaire Score &gt; 14 . Subjects suffer type II Diabetes Mellitus . Subject health condition would prevent him/her fulfil study requirement judge investigator basis medical history routine laboratory test result . Subject uncontrolled hypertension ( systolic blood pressure ≥140 mm Hg diastolic blood pressure ≥90 mm Hg ) define average blood pressure measure screen well randomization . Subject history presence clinically significant cardiac , renal , hepatic , endocrine , pulmonary , biliary , gastrointestinal , pancreatic , neurologic disorder , judgment Investigator , would interfere subject 's ability provide inform consent , comply study protocol ( might confound interpretation study result ) , put subject undue risk . Subject history , judgment investigator , psychological illness condition interfere subject 's ability understand requirement study . Subject history presence oncological disorder . Pregnant/ plan pregnant study period , lactate , woman childbearing potential unwilling commit use medically approve form contraception throughout study period . Use psychotropic medication within four week screen throughout study . Use antibiotic sign active systemic infection . Treatment visit reschedule allow subject wash antibiotic least five day prior test visit . Subject exposure nonregistered drug product within 30 day prior screen visit . Use dietary supplement herbal product . Recent history ( within 12 month screen visit 1 ) strong potential alcohol substance abuse . Subject know allergy sensitivity herbal product ( ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>